Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P23249

Entry ID Method Resolution Chain Position Source
AF-P23249-F1 Predicted AlphaFoldDB

47 variants for P23249

Variant ID(s) Position Change Description Diseaes Association Provenance
rs227532316 41 H>Q No EVA
rs3388651517 48 G>R No EVA
rs3388658695 50 P>S No EVA
rs3388636099 105 S>P No EVA
rs3388643692 108 A>V No EVA
rs13459070 142 H>R No EVA
rs864278832 159 G>R No EVA
rs3393494849 174 T>K No EVA
rs3393024325 175 P>T No EVA
rs3388652905 244 S>R No EVA
rs3388651532 259 P>T No EVA
rs3388659197 271 R>Q No EVA
rs3412942314 287 E>D No EVA
rs3388651527 299 I>T No EVA
rs3388656480 394 R>* No EVA
rs3388651490 402 L>F No EVA
rs3388643671 414 Y>C No EVA
rs3388655893 422 E>* No EVA
rs3388651524 423 L>M No EVA
rs864290441 442 L>R No EVA
rs3388652843 454 P>T No EVA
rs246717088 478 A>S No EVA
rs3388656453 527 P>S No EVA
rs3388644290 529 T>I No EVA
rs3388658653 533 V>D No EVA
rs3393484133 583 S>R No EVA
rs3388658661 611 K>N No EVA
rs3393403540 623 T>S No EVA
rs3393494904 624 L>P No EVA
rs3388652501 686 G>E No EVA
rs3388656455 696 K>T No EVA
rs3388643663 714 Y>F No EVA
rs3388656481 719 N>I No EVA
rs3388652478 726 I>T No EVA
rs3388652816 739 I>L No EVA
rs3388657604 758 V>M No EVA
rs3388656462 772 Q>* No EVA
rs3388644249 774 G>D No EVA
rs30355675 835 R>Q No EVA
rs3388654648 886 Q>R No EVA
rs3388643715 895 F>L No EVA
rs3388644260 940 K>* No EVA
rs3388656454 940 K>E No EVA
rs3388658627 944 G>E No EVA
rs586994849 978 R>C No EVA
rs3388650472 984 Q>H No EVA
rs3388650467 1003 E>G No EVA

No associated diseases with P23249

5 regional properties for P23249

Type Name Position InterPro Accession
domain Helicase MOV-10/SDE3, DEXXQ/H-box helicase domain 499 - 734 IPR026122
domain DNA2/NAM7 helicase, helicase domain 500 - 569 IPR041677-1
domain DNA2/NAM7 helicase, helicase domain 611 - 691 IPR041677-2
domain DNA2/NAM7 helicase-like, C-terminal 700 - 923 IPR041679
domain Upf1-like, C-terminal helicase domain 735 - 940 IPR047187

Functions

Description
EC Number 3.6.4.13 Acting on ATP; involved in cellular and subcellular movement
Subcellular Localization
  • Cytoplasm, P-body
  • Nucleus
  • Cytoplasm
  • Cytoplasm, Cytoplasmic ribonucleoprotein granule
  • Cytoplasm, Stress granule
  • In young mouse (P2) neurons, localizes both in nucleus and cytoplasm, but in the adulthood it is only cytoplasmic (PubMed:28662698)
  • Co-enriched in cytoplasmic foci with TUT4 (By similarity)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
cytoplasmic ribonucleoprotein granule A ribonucleoprotein granule located in the cytoplasm.
cytoplasmic stress granule A dense aggregation in the cytosol composed of proteins and RNAs that appear when the cell is under stress.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
P granule A small cytoplasmic, non-membranous RNA/protein complex aggregate in the primordial germ cells of many higher eukaryotes.
P-body A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA-mediated gene silencing.

4 GO annotations of molecular function

Name Definition
5'-3' RNA helicase activity Unwinding of an RNA helix in the 5' to 3' direction, driven by ATP hydrolysis.
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
ATP hydrolysis activity Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient.
RNA binding Binding to an RNA molecule or a portion thereof.

8 GO annotations of biological process

Name Definition
3'-UTR-mediated mRNA destabilization An mRNA destabilization process in which one or more RNA-binding proteins associate with the 3'-untranslated region (UTR) of an mRNA.
defense response to virus Reactions triggered in response to the presence of a virus that act to protect the cell or organism.
miRNA-mediated gene silencing A post-transcriptional gene silencing pathway in which regulatory microRNAs (miRNAs) elicit silencing of specific target genes. miRNAs are endogenous 21-24 nucleotide small RNAs processed from stem-loop RNA precursors (pre-miRNAs). Once incorporated into a RNA-induced silencing complex (RISC), miRNAs can downregulate gene expression by either of two posttranscriptional mechanisms: endonucleolytic cleavage of the RNA (often mRNA) or mRNA translational repression, usually accompanied by poly-A tail shortening and subsequent degradation of the mRNA. miRNAs are present in all the animals and in plants, whereas siRNAs are present in lower animals and in plants.
miRNA-mediated gene silencing by mRNA destabilization An RNA interference pathway in which microRNAs (miRNAs) direct the cleavage of target mRNAs. Once incorporated into a RNA-induced silencing complex (RISC), a miRNA base pairing with near-perfect complementarity to the target mRNA will typically direct targeted endonucleolytic cleavage of the mRNA. Many plant miRNAs downregulate gene expression through this mechanism.
negative regulation of transposition, RNA-mediated Any process that decreases the frequency, rate or extent of RNA-mediated transposition. RNA-mediated transposition is a type of transpositional recombination which occurs via an RNA intermediate.
positive regulation of mRNA catabolic process Any process that increases the rate, frequency, or extent of a mRNA catabolic process, the chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.
post-transcriptional gene silencing by RNA A posttranscriptional gene silencing pathway in which regulatory RNAs elicit silencing of specific target genes, either by mRNA destabilization or inhibition of translation.
regulation of neuron projection arborization Any process that modulates the frequency, rate or extent of the process in which the anatomical structures of a neuron projection are generated and organized into branches.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5ZKD7 MOV10 Putative helicase MOV-10 Gallus gallus (Chicken) PR
Q9HCE1 MOV10 Helicase MOV-10 Homo sapiens (Human) PR
Q8CFQ3 Aqr RNA helicase aquarius Mus musculus (Mouse) PR
Q8GYD9 SDE3 Probable RNA helicase SDE3 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MPSKFSCRKL RETGQRFESF LAERGLDLET DRERLRTIYN HDFKPSYGTP APGFSSMLYG
70 80 90 100 110 120
MKIANLAFVT KTRVRFFKLD RWADVQLPEK RRIKPGSNIS KQHRSLLARI FHDRAEYLHG
130 140 150 160 170 180
KHGVDVEVQG PHEARDGQLL IHLDLNRKEV LTLRLRNGGS KPVTLTHLFP LCWTPQFVFY
190 200 210 220 230 240
HGEQDLPCPL GPGESYELHI YCKTSIVGYF PATVLWELLG PGESGAEGAE TFYIARFLAA
250 260 270 280 290 300
VAHSPLAAQL KPTTPFKRPP RLTRNSVLTN RIEEGERPDR AKGYELELSL ALGTYYPPIL
310 320 330 340 350 360
LRQLLPTLLQ GPSIFTAPKE VAEIKAQLET TLKSRNYEVK LRLLLHLEEL QMEHDIRHYD
370 380 390 400 410 420
LDSVPMTWDP VDQNPRLLTL EVPGVAESRP SVLRGDHLFA LLSSETQQDD PVTYKGFVHK
430 440 450 460 470 480
VELDRVKLSF STSLLSRFVD GLTFKVNFTF NRQPLRVQHR ALELTGRWVL WPMLFPVASR
490 500 510 520 530 540
GVSLLPSDVK FKLYDRSLES NPEQLQAMKH IVRGTTRPAP YIIFGPPGTG KTVTLVEAIK
550 560 570 580 590 600
QVVKHLPKAH ILACAPSNSG ADLLCQRLRV HLPSSIYRLL APSRDIRMVP EDIKTCCNWD
610 620 630 640 650 660
AKKGEYVYPA KKHLQQYRVL ITTLITASRL VSAQFPIDHF THIFIDEAGH CMEPESLVAI
670 680 690 700 710 720
AGLMDVKETG NPGGQLVLAG DPRQLGPVLR SPLALKHGLG YSLLERLLAY NSLYKKGPNG
730 740 750 760 770 780
YDPQFITKLL RNYRSHPTIL DIPNQLYYDG ELQACADVVD RERFCRWEGL PQQGFPIIFH
790 800 810 820 830 840
GVMGKDEREG NSPSFFNPEE AATVTSYLKQ LLAPSSKKGK ARLSPRNVGV ISPYRKQVEK
850 860 870 880 890 900
IRYCITKLDR ELRGLDDIKD LKVGSVEEFQ GQERSVILIS TVRSSQSFVQ LDLDFNLGFL
910 920 930 940 950 960
KNPKRFNVAV TRAKALLIVV GNPLLLGHDP DWKTFLEFCK ENGGYTGCPF PAKLDLQQGQ
970 980 990 1000
DLLQGLSKLS PSTSGPRRHQ NLPQEREGEG GLPLQVEPEW RNEL